End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.33 CNY | +2.06% |
|
+5.04% | -7.09% |
01-29 | BCHT Biotechnology to Acquire 33% of Chuanxin Biopharma | MT |
10-25 | Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2024 | CI |
EPS & Dividend: Changchun BCHT Biotechnology Co.
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Dividend per Share 2 | - | 0.15 | 0.15 | 0.1633 | 0.1967 | 0.24 |
Rate of return | - | 0.22% | 0.27% | 0.7% | 0.84% | 1.03% |
EPS 2 | 0.62 | 0.44 | 1.21 | 1.67 | 1.822 | 2.36 |
Distribution rate | - | 34.1% | 12.4% | 9.78% | 10.8% | 10.2% |
Reference price 2 | 68.60 | 69.11 | 54.81 | 23.33 | 23.33 | 23.33 |
Nbr of stocks (in thousands) | 412,841 | 412,841 | 412,841 | 413,658 | 413,658 | - |
Announcement Date | 2/18/22 | 2/24/23 | 2/23/24 | - | - | - |
Past dividends: Changchun BCHT Biotechnology Co.
2024-05-23 | Annual 0.15 CNY |
2023-06-11 | Annual 0.15 CNY |
2022-07-14 | Annual 0.1 CNY |
Upcoming events: Changchun BCHT Biotechnology Co.
Yield (Y) | Yield (Y+1) | P/E ratio (Y) | Price to Book (Y) | EV / Sales (Y) | ||
---|---|---|---|---|---|---|
0.7% | 0.84% | 13.97x | 2.14x | - | ||
1.67% | 1.77% | 20.98x | 2.12x | 3.21x | ||
2.73% | 2.79% | 16.24x | 1.3x | 1.61x | ||
- | - | 16.89x | 14.74x | 8.54x | ||
0.31% | 0.31% | 83.27x | 5.07x | 4.9x | ||
-.--% | -.--% | 151.02x | 28.01x | 18.5x | ||
0.48% | 0.69% | 45.83x | 4.27x | 8.41x | ||
0.85% | 1.38% | 13.52x | 1.17x | - | ||
- | - | 36.57x | - | - | ||
- | - | - | - | - | ||
Average | percentage-no-prefix | percentage-no-prefix | 44.25x | 7.35x | 7.53x | |
Weighted average by Cap. | percentage-no-prefix | percentage-no-prefix | 34.53x | 5.07x | 4.91x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -

MarketScreener is also available in this country: United States.
Switch edition